DoD Lupus, Transformative Vision Award | W81XWH 22 LRP TVA

Opportunity Information: Apply for W81XWH 22 LRP TVA

The Department of Defense Lupus Research Program (LRP) Transformative Vision Award (TVA) is a competitive funding opportunity aimed at projects with an unusually bold and practical plan to dramatically improve the quality of life for people living with lupus. The program is specifically focused on interventions that can make a near-term difference, meaning applicants are expected to move beyond early discovery work and translate research ideas into a testable approach that can plausibly improve day-to-day outcomes for patients. The intervention can be targeted at the individual level (for example, improving symptoms, functioning, or self-management) and/or at the healthcare system level (for example, care delivery models, access, coordination, or clinical workflows). Projects may address quality-of-life challenges for lupus patients of any age, and the announcement explicitly welcomes work relevant to populations with disproportionate lupus burdens.

A central expectation is impact: the application has to make a clear, explicit case that, if successful, the work would meaningfully improve lupus patients lives. The TVA is positioned as a high-risk, high-reward mechanism, but it is not meant for speculative concepts without support. Preliminary data are required, and the research strategy should reflect a strong scientific rationale and thoughtful methodology grounded in a deep understanding of lupus. Proposed approaches may be novel or may build on existing literature and evidence, as long as the logic is rigorous and the plan is designed to test and achieve the stated transformative vision.

Program fit also matters. Applications must address at least one of the FY22 LRP Focus Areas designated for the Transformative Vision Award (the specific focus areas are referenced in the full announcement). The research team is expected to have the expertise and track record needed to carry out the project successfully, and the program encourages meaningful collaborations through an optional Partnering Principal Investigator structure. Under this option, one investigator serves as the Initiating PI handling most submission administration, and up to two additional Partnering PIs may participate; all PIs must contribute substantially to the projects design and core application components. If funded, each PI is named on an individual award within their organization.

One distinctive and non-negotiable requirement is integrated consumer advocate involvement. Every application must include one or more consumer advocates who are involved throughout the project, not just in a ceremonial or advisory capacity. These advocates must be individuals diagnosed with lupus or caregivers, active in a lupus advocacy organization, and independent of participating institutions (they cannot be employees of the organizations on the application). The intent is for advocates to provide objective, patient-centered input on the research question, study design, oversight, recruitment, evaluation, and other key decisions, with ongoing, well-integrated engagement. The advocates are expected to be knowledgeable about current lupus issues and to have sufficient background or training to contribute meaningfully to research discussions.

The TVA permits human subjects research and clinical trials, which signals that the program is open to direct testing of interventions in people when appropriate. At the same time, animal research is not allowed under this announcement, reinforcing that the award is focused on translation and near-term quality-of-life outcomes rather than preclinical development.

From a funding and administrative standpoint, awards are made as assistance agreements, meaning they can be issued as either a grant or a cooperative agreement depending on how much substantial involvement the Department of Defense anticipates during the project. If the agency expects no substantial involvement, a grant is used; if the agency expects collaboration, participation, or intervention during performance, a cooperative agreement is used, and the specific involvement is documented. The total budget for the full period of performance is capped at $2,500,000 in total costs, and applicants are expected to propose a budget that is appropriate and well-justified within the program limits.

In terms of scale and timing, the solicitation (W81XWH-22-LRP-TVA) was posted by the Department of Defense, U.S. Army Medical Research Acquisition Activity (USAMRAA), with an original closing date of September 1, 2022. The program anticipated funding approximately one award, with roughly $2.5 million set aside, contingent on federal fund availability and the results of scientific and programmatic review. The announcement indicated awards would be made no later than September 30, 2023, using FY22 funds that were scheduled to expire for use on that same date, emphasizing that the program was operating under tight fiscal-year constraints. Eligible applicants were broadly defined as unrestricted (open to many entity types), subject to any additional eligibility clarifications in the full announcement text.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Lupus, Transformative Vision Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on May 17, 2022.
• Applicants must submit their applications by Sep 01, 2022. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 22 LRP TVA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: